文献速递肿瘤 PET/CT

术前18F-FDG PET/CT预测肝细胞癌微血管侵犯:一项多中心回顾性队列研究

Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-11-22

本研究纳入7所大学医院158例巴塞罗那临床肝癌分期0或A期肝细胞癌患者,术前接受18F-FDG PET/CT检查,评估肿瘤FDG摄取(以肿瘤与正常肝标准化摄取比值TLR表示)对微血管侵犯(MVI)的预测价值。多因素分析显示TLR、血清甲胎蛋白(AFP)水平和肿瘤大小与MVI存在显著关联(P < 0.001),TLR的ROC曲线下面积(AUC)为0.704,联合TLR、肿瘤大小和AFP的预测模型AUC为0.756。结论认为TLR是术前预测HCC患者MVI的影像生物标志物。

要点

  • 158例BCLC 0/A期HCC患者中76例(48.1%)存在MVI。
  • TLR、AFP和肿瘤大小与MVI显著相关(P < 0.001),多结节与MVI无显著关联(P = 0.563)。
  • TLR预测MVI的AUC为0.704,联合TLR、肿瘤大小和AFP的模型AUC为0.756。

核心结论

  • 经FDG PET/CT测量的肿瘤FDG摄取(TLR)是术前预测HCC患者MVI的影像生物标志物。

研究设计与样本

  • 多中心回顾性队列研究,纳入7所大学医院158例BCLC 0或A期HCC患者(中位年龄57岁,四分位距50-64岁),术前接受18F-FDG PET/CT后行根治性手术。
  • 采用 logistic 回归分析筛选与MVI相关的参数,并用ROC曲线评估TLR及其他临床变量的预测效能。

主要发现

  • 158例中76例(48.1%)存在MVI。
  • 多因素 logistic 回归显示TLR、血清AFP水平和肿瘤大小与MVI存在显著关联(P < 0.001),多结节与MVI无显著关联(P = 0.563)。
  • 预测MVI的AUC以TLR最高(AUC = 0.704),其次为肿瘤大小(AUC = 0.685)和AFP(AUC = 0.670)。
  • 联合TLR、肿瘤大小和AFP的多因素 logistic 回归模型AUC为0.756。

关键数值与推荐

  • TLR预测MVI的AUC = 0.704。
  • 肿瘤大小预测MVI的AUC = 0.685。
  • AFP预测MVI的AUC = 0.670。
  • 联合TLR、肿瘤大小和AFP的模型预测MVI的AUC = 0.756。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to assess the potential of tumor 18F-fluorodeoxyglucose (FDG) avidity as a preoperative imaging biomarker for the prediction of microvascular invasion (MVI) of hepatocellular carcinoma (HCC). METHODS: One hundred and fifty-eight patients diagnosed with Barcelona Clinic Liver Cancer stages 0 or A HCC (median age, 57 years; interquartile range, 50-64 years) who underwent 18F-FDG positron emission tomography with computed tomography (PET/CT) before curative surgery at seven university hospitals were included. Tumor FDG avidity was measured by tumor-to-normal liver standardized uptake value ratio (TLR) of the primary tumor on FDG PET/CT imaging. Logistic regression analysis was performed to identify significant parameters associated with MVI. The predictive performance of TLR and other clinical variables was assessed using receiver operating characteristic (ROC) curve analysis. RESULTS: MVI was present in 76 of 158 patients with HCCs (48.1%). Multivariable logistic regression analysis revealed that TLR, serum alpha-fetoprotein (AFP) level, and tumor size were significantly associated with the presence of MVI (P < 0.001). Multinodularity was not significantly associated with MVI (P = 0.563). The area under the ROC curve (AUC) for predicting the presence of MVI was best with TLR (AUC = 0.704), followed by tumor size (AUC = 0.685) and AFP (AUC = 0.670). We were able to build an improved prediction model combining TLR, tumor size, and AFP by using multivariable logistic regression modeling (AUC = 0.756). CONCLUSIONS: Tumor FDG avidity measured by TLR on FDG PET/CT is a preoperative imaging biomarker for the prediction of MVI in patients with HCC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hyun SH, Eo JS, Song BI, et al. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging. 2017. PMID: 29167923. doi:10.1007/s00259-017-3880-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。